Jul 2026
Reprogramming of Glioblastoma-Immune Crosstalk to Overcome Immunotherapy Failure 2258791
A targetable molecular axis linking the bromodomain-containing protein 2 (BRD2) complex to fibronectin-driven immune suppression in mesenchymal-like GBM niches is identified, offering a promising combinatorial therapeutic strategy.
Shuozhi Liu, Lizmarie Garcia-Rivera, Michael A. LaPorta et al.
· Journal of Immunology · 0 citations